Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis
Clinical trial NCT03019029 · COMPLETED
Trial details
- NCT number
- NCT03019029
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2022-03-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.